Search results
Showing 6991 to 7005 of 8221 results
This advice has been updated and replaced by NICE medical technologies guidance 42.
VitalPAC for assessing vital signs of patients in hospital (MIB79)
This advice has been updated and replaced by NICE medtech innovation briefing 205.
This medtech innovation briefing is temporarily unavailable, please contact mibs@nice.org.uk for further information.
Lutonix drug-coated balloon for peripheral arterial disease (MIB72)
NICE withdrew this medtech innovation briefing in October 2019 after the MHRA withdrew support for this type of technology being used in intermittent claudication for arterial disease.
We have moved NG251 to become a 'NICE Review'. This is to better reflect what the purpose of this product is and to help you find relevant content more quickly. The review itself has not changed. See NICE review 1 on DMD Care UK’s guideline on cardiac care of children with dystrophinopathy and females carrying DMD-gene variations.
Discontinued Reference number: GID-TA10474
Lenalidomide with R-CHOP for untreated activated diffuse large B-cell lymphoma [ID1611]
Discontinued Reference number: GID-TA10480
In development Reference number: GID-TA10483 Expected publication date: TBC
Discontinued Reference number: GID-TA10484
ERC1671 for treating progressed or recurrent grade IV glioma (glioblastoma or gliosarcoma) [ID1623]
In development Reference number: GID-TA10489 Expected publication date: TBC
Discontinued Reference number: GID-TA10490
Discontinued Reference number: GID-TA10492
Idasanutlin with cytarabine for treating relapsed or refractory acute myeloid leukaemia [ID1597]
Discontinued Reference number: GID-TA10494
Discontinued Reference number: GID-TA10495
Discontinued Reference number: GID-TA10499